Effects of Plasmalogen Intake on Mood State in Athletes

Frontiers in Cell and Developmental Biology. 2022;10:894734.
Fujino, et al.

Healthy male university athletes were enrolled in this study and assigned to two groups (n = 20) and administered either scallop-derived plasmalogen (2 mg/day) or a placebo for 4 weeks. Mental and physical well-being were evaluated using the POMS 2 (Profile of Mood States 2nd Edition) test, a standardized psychological assessment that quantifies psychological and physical health status. The results showed that the Total Mood Disturbance (TMD) score in the plasmalogen group exhibited a tendency toward reduction compared with the placebo group (p = 0.07). In addition, the subscale scores for Anger–Hostility and Fatigue–Inertia were significantly lower in the plasmalogen group than in the placebo group (p = 0.003 and p = 0.005, respectively), confirming the beneficial effect of scallop-derived plasmalogen in improving negative mood states.